Lineage Cell Therapeutics Inc (LCTX)
1.17
-0.01
(-0.85%)
USD |
NYAM |
May 10, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Total Liabilities (Quarterly): 39.00M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.00M |
| September 30, 2023 | 39.49M |
| June 30, 2023 | 40.43M |
| March 31, 2023 | 44.19M |
| December 31, 2022 | 51.73M |
| September 30, 2022 | 53.60M |
| June 30, 2022 | 54.42M |
| March 31, 2022 | 59.30M |
| December 31, 2021 | 83.65M |
| September 30, 2021 | 11.62M |
| June 30, 2021 | 11.15M |
| March 31, 2021 | 11.36M |
| December 31, 2020 | 12.82M |
| September 30, 2020 | 12.91M |
| June 30, 2020 | 14.39M |
| March 31, 2020 | 14.12M |
| December 31, 2019 | 14.23M |
| September 30, 2019 | 17.46M |
| June 30, 2019 | 19.93M |
| March 31, 2019 | 22.48M |
| December 31, 2018 | 9.414M |
| September 30, 2018 | 6.519M |
| June 30, 2018 | 7.50M |
| March 31, 2018 | 7.94M |
| December 31, 2017 | 8.978M |
| Date | Value |
|---|---|
| September 30, 2017 | 12.88M |
| June 30, 2017 | 15.17M |
| March 31, 2017 | 15.52M |
| December 31, 2016 | 12.06M |
| September 30, 2016 | 11.33M |
| June 30, 2016 | 10.28M |
| March 31, 2016 | 20.52M |
| December 31, 2015 | 18.21M |
| September 30, 2015 | 15.92M |
| June 30, 2015 | 14.66M |
| March 31, 2015 | 12.19M |
| December 31, 2014 | 12.18M |
| September 30, 2014 | 16.70M |
| June 30, 2014 | 19.40M |
| March 31, 2014 | 12.59M |
| December 31, 2013 | 15.47M |
| September 30, 2013 | 5.485M |
| June 30, 2013 | 5.376M |
| March 31, 2013 | 5.315M |
| December 31, 2012 | 5.454M |
| September 30, 2012 | 3.659M |
| June 30, 2012 | 4.087M |
| March 31, 2012 | 3.147M |
| December 31, 2011 | 4.372M |
| September 30, 2011 | 3.959M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.15M
Minimum
Jun 2021
83.65M
Maximum
Dec 2021
31.88M
Average
19.93M
Median
Jun 2019
Total Liabilities (Quarterly) Benchmarks
| Acumen Pharmaceuticals Inc | 43.15M |
| Sarepta Therapeutics Inc | 2.263B |
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 101.02M |
| Shareholders Equity (Quarterly) | 63.42M |
| Current Ratio | 2.140 |